-
1 Comment
American Shared Hospital Services is currently in a long term uptrend where the price is trading 16.3% above its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.9.
American Shared Hospital Services's total revenue sank by 11.9% to $5M since the same quarter in the previous year.
Its net income has dropped by 226.7% to $-209K since the same quarter in the previous year.
Finally, its free cash flow fell by 36.2% to $1M since the same quarter in the previous year.
Based on the above factors, American Shared Hospital Services gets an overall score of 2/5.
| Exchange | NYSE MKT |
|---|---|
| CurrencyCode | USD |
| ISIN | US0295951059 |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Market Cap | 19M |
|---|---|
| PE Ratio | 8.51 |
| Target Price | 4.84 |
| Beta | 0.35 |
| Dividend Yield | None |
American Shared Hospital Services provides technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services. It operates in two segments, Leasing and Retail. The company leases nine Gamma Knife systems and one proton beam radiation therapy (PBRT) system; and provides planning, installation, reimbursement, and marketing support services. It also owns and operates two single-unit Gamma Knife facilities that provides radiosurgery services directly to the patient. The company markets its solutions to cancer treatment centers, health systems, and cancer networks worldwide. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for AMS using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
